IMRX
Immuneering Corp
4.30$
-0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 88.3% | 86.8% | 84.6% | 82.6% | 80.6% | 75.1% | 75.4% | 69.2% | 95.0% | 76.0% | 75.1% | 78.2% | |
| 59.7% | 57.9% | 75.3% | 77.5% | 65.9% | 68.6% | 70.8% | 65.8% | 94.4% | 55.5% | 22.0% | 20.5% | |
| 85.4% | 83.5% | 81.0% | 77.5% | 73.9% | 68.6% | 70.8% | 65.8% | 94.4% | 74.5% | 72.9% | 74.2% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | 1.7% | |
| 5.9% | 6.5% | 7.6% | 8.7% | 9.8% | 12.7% | 13.2% | 16.7% | 2.8% | 2.9% | 3.1% | 3.3% | |
| 0.3% | 0.4% | 0.4% | 0.5% | 0.5% | 0.7% | 0.7% | 0.8% | 0.1% | 0.1% | 0.1% | 0.2% | |
| 8.7% | 11.7% | 10.5% | 14.0% | 15.8% | 21.5% | 17.4% | 27.8% | 5.4% | 5.8% | 3.9% | 5.6% | |
| 4.9% | 7.6% | 5.9% | 8.8% | 10.1% | 14.2% | 10.1% | 18.7% | 4.0% | 4.3% | 2.3% | 4.0% | |
| 0.3% | 0.3% | 0.3% | 0.4% | 0.5% | 0.6% | 0.7% | 0.9% | 0.2% | 0.2% | 0.2% | 0.2% | |
| 1.7% | 2.1% | 2.6% | 3.4% | 2.8% | 3.7% | 2.6% | 6.0% | 0.7% | 0.7% | 0.7% | 1.7% | |
| 91.3% | 88.3% | 89.5% | 86.0% | 84.2% | 78.5% | 82.6% | 72.2% | 94.6% | 94.2% | 96.1% | 94.4% | |
| -130.1% | -159.1% | -201.8% | -248.6% | -300.8% | -425.5% | -472.2% | -633.5% | -111.5% | -120.8% | -136.8% | -153.9% | |
| 25.7% | 28.5% | 33.4% | 38.5% | 43.5% | 58.9% | 70.1% | 89.8% | 16.5% | 27.8% | 30.1% | 32.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.